ChiCTR1800015239Active, not recruiting治疗新技术临床试验
糖皮质激素联合他克莫司治疗急性百草枯中毒的临床研究
自费1 site in 1 country100 target enrollmentStarted: March 20, 2018Last updated:
Trial Snapshot
- Phase
- 治疗新技术临床试验
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- 肺部 CT
Study Overview
Brief Summary
研究糖皮质激素联合他克莫司对急性百草枯中毒的临床疗效，探讨急性百草枯中毒的有效治疗方法。
Study Design
- Study Type
- 观察性研究
- Primary Purpose
- 单臂
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •（1）急性口服百草枯中毒患者，年龄大于 12 岁；
- •（2）签署知情同意书。
Exclusion Criteria
- •（1）对上述药物过敏者；
- •（2） 患者及家属依从性不佳者。
Arms & Interventions
连续病例
糖皮质激素联合他克莫司
Outcomes
Primary Outcomes
肺部 CT
肝肾功能
血常规
尿常规
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
比较单用他克莫司与糖皮质激素联合环磷酰胺治疗成人原发性膜性肾病的有效性及安全性：一项多中心随机、对照开放性研究ChiCTR1800016140自筹
Unknown
Not Applicable
糖皮质激素联合生物制剂治疗重症免疫检查点抑制剂相关结肠炎的研究ChiCTR2300069644中央高水平医院临床科研业务费资助及项目编号
Not yet recruiting
Phase 3
Comparative Clinical Study of Kariradi Vaginal Wash and Clotrimazole in ShwetapradarCTRI/2024/07/069717DrApurva Chandrakant Karande68
Recruiting
Phase 3
Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDaCrohn's disease2024-519269-23-00Medical University Of Warsaw138
Unknown
Not Applicable
糖皮质激素联合肿瘤坏死因子抑制剂治疗免疫相关表皮坏死松解症ChiCTR2300070188北京协和医院中央高水平医院临床科研专项 (重点培育)：抗肿瘤免疫相关不良事件规范化诊疗体系建设（2022-PUMCH-C-054）